Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 601–700 of 1,001
CYP1B1 as a therapeutic target in cardio-oncology
Carrera, A. N., Grant, M. K. O., & Zordoky, B. N. M. (2020) · Clinical Science · doi:10.1042/cs20200310 · Cited by 47
Mesenchymal Stem Cells for Mitigating Radiotherapy Side Effects
Wang, K., Cui, W.-W., Xu, Y., Tao, A., Lan, T., Li, T., & Luo, L. (2021) · Cells · doi:10.3390/cells10020294 · Cited by 46
“There is no evidence showing the existing dose threshold that would not damage the cell [10].”
BackgroundNormal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities
Prasanna, P. G. S., Rawojć, K., Guha, C., Buchsbaum, J. C., Miszczyk, J. U., & Coleman, C. N. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.02.043 · Cited by 49
Errahmani, M. Y., Locquet, M., Spoor, D. S., Jimenez, G., Camilleri, J., Bernier, M., Broggio, D., Monceau, V., Ferrières, J., Thariat, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.892882 · Cited by 44
“4% in lifetime risk of coronary events for each Gy (Gray) of radiation to the heart has been demonstrated in women with previous BC having received radiation (6), reaching 16.”
BackgroundCardiac Outcomes in Survivors of Pediatric and Adult Cancers
Nathan, P. C., Amir, E., & Abdel-Qadir, H. M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.065 · Cited by 52
“In women treated with radiation for breast cancer, rates of major coronary events have been shown to increase linearly with mean dose to the heart by approximately 7% per Gray of radiation.(31) The risk of cardiovascular disease after radiotherapy is further increased by exposure to other cardiotoxic chemotherapy agen…”
BackgroundBates, J. E., Shrestha, S., Liu, Q., Smith, S. A., Mulrooney, D. A., Leisenring, W. M., Gibson, T. M., Robison, L. L., Chow, E. J., Oeffinger, K. C., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02320 · Cited by 43
Risk and Risk Reduction of Major Coronary Events Associated With Contemporary Breast Radiotherapy
Brenner, D. J., Shuryak, I., Jozsef, G., DeWyngaert, K. J., & Formenti, S. C. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11790 · Cited by 45
“1,4 Estimation of the absolute risk of radiation-related ischemic heart disease for an individual woman requires (1) her estimated cardiac radiation dose for the radiotherapy treatment plan under consideration, (2) the percentage increase in ischemic heart disease risk per unit cardiac radiation dose, and (3) the woma…”
BackgroundHeggemann, F., Grotz, H., Welzel, G., Dösch, C., Hansmann, J., Kraus-Tiefenbacher, U., Attenberger, U. I., Schönberg, S. O., Borggrefe, M. M., Wenz, F. K., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.2287 · Cited by 43
A New Era of Low-Dose Radiation Epidemiology
Kitahara, C. M., Linet, M. S., Rajaraman, P., Ntowe, E., & de González, A. B. (2015) · Current Environmental Health Reports · doi:10.1007/s40572-015-0055-y · Cited by 46
Imaging particle beams for cancer treatment
Polf, J., & Parodi, K. (2015) · Physics Today · doi:10.1063/pt.3.2945 · Cited by 43
Luo, L. Y., Cuaron, J. J., Braunstein, L. Z., Gillespie, E. F., Kahn, A. J., McCormick, B. L., Mah, D. W., Chon, B. H., Tsai, H. K., Powell, S. N., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.10.002 · Cited by 43
New therapeutic insights into radiation-induced myocardial fibrosis
Ma, C., Zhao, X., & Li, Y. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319868383 · Cited by 43
“(2) Modalities with the best reproducibility are preferred.”
BackgroundSun, T., Lin, X., Tong, Y., Liu, X., Pan, L., Tao, C., Duan, J., & Yin, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01456 · Cited by 43
“(2) found that there was a linear relationship between the MHD and the incidence of ischemic heart disease, which increased by 7.”
BackgroundMajumdar, S. K. D., Amritt, A., Dhar, S. S., Barik, S. K., Beura, S. S., Mishra, T. S., Muduly, D. K., Dash, A., & Parida, D. K. (2022) · Cureus · doi:10.7759/cureus.23568 · Cited by 43
“The benefit of radiotherapy comes at the expense of the heart [4], lung [5,6], and secondary breast cancer risk [7].”
BackgroundIs there a preferred IMRT technique for left‐breast irradiation?
Jeulink, M., Dahele, M. R., Meijnen, P., Slotman, B. J., & Verbakel, W. F. A. R. (2015) · Journal of Applied Clinical Medical Physics · doi:10.1120/jacmp.v16i3.5266 · Cited by 43
“(21) Important issues that remain unresolved include, for example: 1) the optimal trade-off between low and high heart doses for treatment planning and the effect of volume; 2) which part(s) of the heart are most important to spare (for instance, Darby et al.(2) found that the mean dose to the LAD was not a significan…”
BackgroundComsa, D. C., Barnett, E., Le, K., Mohamoud, G., Zaremski, D., Fenkell, L. L., & Kassam, Z. (2013) · Practical Radiation Oncology · doi:10.1016/j.prro.2013.10.006 · Cited by 43
Sakka, M., Kunzelmann, L., Metzger, M., & Grabenbauer, G. G. (2017) · Strahlentherapie und Onkologie · doi:10.1007/s00066-017-1167-0 · Cited by 45
“indicated that a reduction in radiation dose to the heart decreased the incidence of ischemic heart disease among breast cancer patients [7].”
BackgroundEfficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer
Zhou, P., Du, Y., Zhang, Y., Zhu, M., Li, T., Tian, W., Wu, T., & Xiao, Z. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.28136 · Cited by 42
Varlotto, J. M., Yao, A. N., DeCamp, M. M., Ramakrishna, S., Recht, A., Flíckinger, J. C., Andrei, A., Reed, M. F., Toth, J. W., Fizgerald, T. J., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.12.028 · Cited by 42
Lo, Q., Hee, L., Batumalai, V., Allman, C., Macdonald, P. S., Lonergan, D., Delaney, G. P., & Thomas, L. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.05.030 · Cited by 45
Nakatsuma, K., Shiomi, H., Morimoto, T., Watanabe, H., Nakagawa, Y., Furukawa, Y., Kadota, K., Andò, K., Ono, K., Shizuta, S., et al. (2018) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcy014 · Cited by 42
Cardiotoxicity of Contemporary Breast Cancer Treatments
Chuy, K. L., & Yu, A. F. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0646-1 · Cited by 42
Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy
Milgrom, S. A., Varghese, B. T., Gladish, G. W., Choi, A., Dong, W., Patel, Z. S., Chung, C. D., Rao, A., Pinnix, C. C., Gunther, J. R., et al. (2019) · Journal of Cardiovascular Imaging · doi:10.4250/jcvi.2019.27.e38 · Cited by 43
Roule, V., Verdier, L., Blanchart, K., Ardouin, P., Lemaître, A., Bignon, M., Sabatier, R., Alexandre, J., & Beygui, F. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01352-0 · Cited by 42
Zhang, Y., Huang, Y., Ding, S., Yuan, X., Shu, Y., Liang, J., Mao, Q., Jiang, C., & Li, J. (2021) · Radiation Oncology · doi:10.1186/s13014-021-01895-2 · Cited by 42
“Darby SC, Ewertz M, Mcgale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer.”
BackgroundInfluentialSteingart, R. M., Yadav, N., Manrique, C. R., Carver, J. R., & Liu, J. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.09.010 · Cited by 41
“Women with preexisting cardiac risk factors have greater absolute increases in risk from RT than other women.(73)”
BackgroundCardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
Boekel, N. B., Schaapveld, M., Gietema, J. A., Rutgers, E. J. T., Versteegh, M. I. M., Visser, O. J., Aleman, B. M. P., & van Leeuwen, F. E. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju156 · Cited by 44
“Recently, a dose–effect relationship for ischemic heart disease (IHD) was shown in BC patients treated with radiotherapy (13).”
BackgroundIto, H., Itasaka, S., Sakanaka, K., Araki, N., Mizowaki, T., & Hiraoka, M. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw078 · Cited by 41
“In an analysis of postoperative radiation therapy for breast cancer, a history of prior ischemic heart disease and greater age increased the risk of post–radiation therapy ischemic heart disease [19].”
BackgroundRadiation-induced heart disease in lung cancer radiotherapy: A dosimetric update
Ming, X. G., Feng, Y., Yang, C., Wang, W., Wang, P., & Deng, J. (2016) · Medicine · doi:10.1097/md.0000000000005051 · Cited by 44
“As demonstrated by Darby et al,[17] for every gray of mean heart dose increase, the major coronary events increased by 7.4%.”
BackgroundMethodResultInfluentialConcurrent administration of anti-HER2 therapy and radiotherapy: Systematic review
Mignot, F., Ajgal, Z. C., Xu, H., Géraud, A., Chen, J., Mégnin-Chanet, F., & Kirova, Y. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.006 · Cited by 41
Cardiovascular and Cancer Risk: The Role of Cardio-oncology
Coviello, J. S. (2018) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2018.9.2.3 · Cited by 48
“Cardiovascular risk factors can be enhanced during cancer treatment and lead to an increased risk of coronary artery disease (CAD) in survivors (Chang, Moudgil, Scarabelli, Okwuosa, & Yeh, 2017a; Chang, Okwuosa, Scarabelli, Moudgil & Yeh, 2017b; Darby et al., 2013; Greenlee et al., 2017; Hague et al., 2014; Marmagkiol…”
BackgroundInfluentialPericardial disease after breast cancer radiotherapy
Marinko, T. (2018) · Radiology and Oncology · doi:10.2478/raon-2018-0035 · Cited by 43
Tang, S., Otton, J. M., Holloway, L. C., Delaney, G. P., Liney, G. P., George, A., Jameson, M., Tran, D. D., Batumalai, V., Thomas, L., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.09.021 · Cited by 41
Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
Ntentas, G., Dědečková, K., Andrlík, M., Aznar, M. C., George, B., Kubeš, J., Darby, S. C., & Cutter, D. J. (2019) · Practical Radiation Oncology · doi:10.1016/j.prro.2019.01.006 · Cited by 41
“Minor acute toxicities were reported for some patients, including grade 1 dysphagia,(16) grade 1 radiodermatitis,(6) grade 2 leukopenia,(4) grade 1 mucositis,(3) and grade 1 anaemia.(1) Other patient characteristics are shown in Table 1.”
BackgroundSelf-citationPredictors of cardiac and lung dose sparing in DIBH for left breast treatment
Cao, N., Kalet, A. M., Young, L. A., Fang, L. C., Kim, J. N., Mayr, N. A., & Meyer, J. (2019) · Physica Medica · doi:10.1016/j.ejmp.2019.09.240 · Cited by 41
Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks
Gaasch, A., Schönecker, S., Simonetto, C., Eidemüller, M., Pazos, M., Reitz, D., Rottler, M., Freislederer, P., Braun, M., Würstlein, R., et al. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01520-8 · Cited by 41
Jumeau, R., Özşahin, M., Schwitter, J., Eliçin, O., Reichlin, T., Roten, L., Andratschke, N. H., Mayinger, M. C., Saguner, A. M., Steffel, J., et al. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00108 · Cited by 41
Jang, B., Cha, M., Kim, H. J., Oh, S., Wu, H., Kim, E., Kim, B. H., Kim, J. S., & Chang, J. H. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.09.050 · Cited by 42
Cardiovascular health: an important component of cancer survivorship
Cleary, S., Rosen, S. D., Gilbert, D. C., & Langley, R. E. (2023) · BMJ Oncology · doi:10.1136/bmjonc-2023-000090 · Cited by 51
Deep learning–based automatic segmentation of cardiac substructures for lung cancers
Chen, X., Mumme, R. P., Corrigan, K. L., Mukai-Sasaki, Y., Koutroumpakis, E., Palaskas, N. L., Nguyen, C. M., Zhao, Y. J., Huang, K., Yu, C., et al. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.110061 · Cited by 44
Differences in Risk Factors for Coronary Atherosclerosis According to Sex
Kim, H. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.2.97 · Cited by 51
Hepp, R., Ammerpohl, M., Morgenstern, C., Nielinger, L., Erichsen, P., Abdallah, A., & Galalae, R. M. (2015) · Strahlentherapie und Onkologie · doi:10.1007/s00066-015-0838-y · Cited by 42
“[6] showed that the magnitude of risk of a major coronary event increased linearly with the mean dose to the heart by 7 % per Gray and with no apparent threshold below which there was no risk.”
BackgroundSex Differences in the Pathophysiology, Treatment, and Outcomes in IHD
Sanghavi, M., & Gulati, M. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0511-z · Cited by 46
Mann, M. C., Exner, D. V., Hemmelgarn, B. R., Turin, T. C., Sola, D. Y., Ellis, L., & Ahmed, S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.01.058 · Cited by 40
Radiation dose distribution in coronary arteries in breast cancer radiotherapy
Nilsson, G., Nyström, P. W., Isacsson, U., Garmo, H., Duvernoy, O., Sjögren, I., Lagerqvist, B., Holmberg, L., & BLOMQVIST, C. P. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1182209 · Cited by 40
“In contrast to previous studies of older RT techniques [11,17] requiring dose estimations of representative average patients, this study is based on detailed information of the individual patient radiation dose in different parts of the heart and coronary arteries, as all the patients have been treated with 3DCRT.”
BackgroundResultThe Principles and Practice of Re-irradiation in Clinical Oncology: An Overview
Dörr, W., & Gabryś, D. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.11.014 · Cited by 40
Selection of external beam radiotherapy approaches for precise and accurate cancer treatment
Shirato, H., Le, Q., Kobashi, K., Prayongrat, A., Takao, S., Shimizu, S., Giaccia, A., Xing, L., & Umegaki, K. (2018) · Journal of Radiation Research · doi:10.1093/jrr/rrx092 · Cited by 35
Hypofractionated radiation treatment in the management of breast cancer
Gupta, A., Ohri, N., & Haffty, B. G. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1489245 · Cited by 40
“4% increase inmajor coronary events per Gy increase in mean heart dose [27]; however, the average mean heart dose of all 1,144 patients with left-sided cancers included in”
BackgroundAutomatic Planning of Whole Breast Radiation Therapy Using Machine Learning Models
Sheng, Y., Li, T., Yoo, S., Yin, F.-F., Blitzblau, R. C., Horton, J. K., Ge, Y., & Wu, Q. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00750 · Cited by 40
“Given the high cure rate and long life expectancy for breast patients, limiting normal tissue injuries such as pneumonitis and ischemic heart disease (24) is critical.”
BackgroundChronic irradiation of human cells reduces histone levels and deregulates gene expression
Lowe, D., Herzog, M., Mosler, T., Cohen, H., Felton, S. J., Beli, P., Raj, K., Galanty, Y., & Jackson, S. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-59163-4 · Cited by 44
Stick, L. B., Lorenzen, E. L., Yates, E. S., Anandadas, C., Andersen, K., Aristei, C., Byrne, O., Hol, S., Jensen, I., Kirby, A. M., et al. (2021) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2021.01.012 · Cited by 40
Wei, T., & Cheng, Y. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1956007 · Cited by 50
“There was a positive correlation between the increase of heart dose during radiation treatment and the incidence of ischemic heart disease (Darby et al. 2013).”
BackgroundCai, G., Li, C., Li, J., Yang, J., Li, C., Sun, L., Li, J., Yu, J., & Meng, X. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.08.013 · Cited by 42
Milo, M. L. H., Møller, D. S., Nyeng, T. B., Hoffmann, L., Nissen, H. D., Jensen, I., Lorenzen, E. L., Thorsen, L. B. J., Nielsen, K. M., Johnsen, S. P., et al. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.109453 · Cited by 40
Lai, T., Hu, Y., Wang, T., Chen, J.-P., Shiau, C.-Y., Huang, P., Lai, I., Tseng, L., Huang, N., & Liu, C. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad462 · Cited by 42
Ischemic Heart Disease in Workers at Mayak PA: Latency of Incidence Risk after Radiation Exposure
Simonetto, C., Azizova, T. V., Grigoryeva, E. S., Kaiser, J. C., Schöllnberger, H., & Eidemüller, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096309 · Cited by 43
“For example, already 5 years after radiotherapy of breast cancer, frequency of major coronary events were significantly associated to dose [2].”
BackgroundAdvances in Radiotherapy for Breast Cancer
Upadhyay, R., & Bazan, J. G. (2023) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2023.03.002 · Cited by 39
Ischaemic heart disease in patients with cancer
Ameri, P., Bertero, E., Lombardi, M., Porto, I., Canepa, M., Nohria, A., Vergallo, R., Lyon, A. R., & López‐Fernández, T. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae047 · Cited by 40
Radiation-Induced Macrovessel/Microvessel Disease
Abe, J., Allen, B. G., Beyer, A., Lewandowski, D., Mapuskar, K. A., Subramanian, V., Tamplin, M. R., & Grumbach, I. M. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.319866 · Cited by 43
Wickberg, Å., Holmberg, L., Adami, H., Magnuson, A., Villman, K., & Liljegren, G. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.6600 · Cited by 44
Delineation of Internal Mammary Nodal Target Volumes in Breast Cancer Radiation Therapy
Jethwa, K. R., Kahila, M. M. H., Hunt, K. N., Brown, L. C., Corbin, K. S., Park, S. S., Yan, E., Boughey, J. C., & Mutter, R. W. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.11.037 · Cited by 39
“Although the emerging data suggest that occult disease in the internal mammary nodes (IMNs) may be a relatively important source of distant spread in some women with breast cancer, IMNI also increases the dose to the heart and lungs, which may have important clinical implications, including increased risks of cardiac…”
BackgroundInfluentialWen, G., Tan, Y., Lan, X., He, Z., Huang, J., Shi, J., Xiao, L., & Huang, X. (2017) · Journal of Cancer · doi:10.7150/jca.21158 · Cited by 39
“However, lung tissue is inevitably affected by irradiation during RT, and radiation-induced lung injury, one of the most common complications of postoperative RT for BC, seriously affects patient quality of life and even increases non-cancer mortality [3, 4].”
BackgroundRenda, G., Patti, G., Lang, I. M., Siller-Matula, J. M., Hylek, E. M., Ambrosio, G., Haas, S. K., & Caterina, R. D. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.004 · Cited by 42
Levis, M., Filippi, A. R., Fiandra, C., Luca, V. D., Bartoncini, S., Vella, D., Ragona, R., & Ricardi, U. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.05.009 · Cited by 39
“…to create dedicated risk-modeling, the estimation of cardiac events is still extremely complex, as many non RT-related factors such as the use of anthracyclines [ 29 ] and/or concomitant cardiovascular risk factors (hypertension, diabetes, dyslipidemia and obesity) [ 17,27 ] may have an impact.”
InfluentialTranslating current biomedical therapies for long duration, deep space missions
Iosim, S., MacKay, M. J., Westover, C. D., & Mason, C. E. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz022 · Cited by 44
Planek, M. I. C., Silver, A. J., Volgman, A. S., & Okwuosa, T. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014668 · Cited by 41
“Modern RT shows promise in limiting cardiotoxicity, but cardiovascular morbidity persists.(17) To reduce the deleterious effects of RT, current changes to RT protocols include computed tomography planning models, 3-dimensional conformal RT, enhanced localization, gated techniques, deep inspiration breath hold, and pro…”
Sase, K., Kida, K., & Furukawa, Y. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.07.014 · Cited by 40
Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging
Podlesnikar, T., Berlot, B., Dolenc, J., Goričar, K., & Marinko, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.887705 · Cited by 45
“5% per each Gy increase in the mean heart dose, both with old and modern RT techniques (3, 85, 86).”
BackgroundFiorentino, A., Mazzola, R., Naccarato, S., Giaj‐Levra, N., Fersino, S., Sicignano, G., Tebano, U., Ricchetti, F., Ruggieri, R., & Alongi, F. (2017) · La radiologia medica · doi:10.1007/s11547-017-0741-y · Cited by 39
“Finally, according to the analysis of the two patient groups with respect to Darby’s study on the risk of cardiac toxicity [23], in Table 4 the inter-patient averages of Dmean to the heart are reported: 11.”
MethodBi, S., Zhu, R., & Dai, Z. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02009-2 · Cited by 38
“All the plans were optimized with the same dose constraints [22] as was detailed in Table 1.”
MethodMiller, K. B., Mi, K. L., Nelson, G. A., Norman, R. B., Patel, Z. S., & Huff, J. L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1008640 · Cited by 42
“Vascular dysfunction and increased risk for cardiovascular disease in response to ionizing radiation has been reported from therapeutic exposures (Swerdlow et al., 2007; Mulrooney et al., 2009; Darby et al., 2013; Wang et al., 2019; Belzile-Dugas and Eisenberg, 2021), accidental exposures (Shimizu et al.”
BackgroundKaidar‐Person, O., Meattini, I., Boersma, L. J., Becherini, C., Cortés, J., Curigliano, G., de Azambuja, E., Harbeck, N., Rugo, H. S., Mastro, L. D., et al. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.110060 · Cited by 38
Rakisheva, A., Farmakis, D. T., Attanasio, A. F., Bayés‐Genís, A., Solal, A. C., Gulati, G., Halle, M., Hill, L., López‐Fernández, T., Lyon, A. R., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3753 · Cited by 41
Brouckaert, O., Schoneveld, A., Truyers, C., Kellen, E., Ongeval, C. V., Vergote, I. B., Moerman, P., Floris, G., Wildiers, H. P. M. W., Christiaens, M. R., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt179 · Cited by 38
Conway, J. L., Conroy, L., Harper, L., Scheifele, M., Li, H., Smith, W. L., Graham, T., Phan, T., & Olivotto, I. A. (2016) · Practical Radiation Oncology · doi:10.1016/j.prro.2016.10.011 · Cited by 38
Kunheri, B., Kotne, S., Nair, S. S., & Makuny, D. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1414_16 · Cited by 38
Prospective Study of Breast Radiation Dermatitis
Drost, L., Li, N., Vesprini, D., Sangha, A., Lee, J., Leung, E., Rakovitch, E., Yee, C., Chow, E., & Ruschin, M. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.03.008 · Cited by 38
Cancer survivors: An expanding population with an increased cardiometabolic risk
Felicetti, F. C., Fortunati, N., & Brignardello, E. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.016 · Cited by 40
Levis, M., Luca, V. D., Fiandra, C., Veglia, S., Fava, A., Gatti, M., Giorgi, M., Bartoncini, S., Cadoni, F., Garabello, D., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.04.014 · Cited by 38
“All these studies indicated a clear relationship between the dose received by the whole heart and the incidence of longterm cardiovascular complications, particularly ischemic events [5,6].”
BackgroundBalaji, K., Yadav, P., BalajiSubramanian, S., Radha, C. A., & Ramasubramanian, V. (2018) · Physica Medica · doi:10.1016/j.ejmp.2018.06.641 · Cited by 38
Monte Carlo investigation on the effect of air gap under bolus in post-mastectomy radiotherapy
Boman, E. L., Ojala, J., Rossi, M. E., & Kapanen, M. K. (2018) · Physica Medica · doi:10.1016/j.ejmp.2018.10.023 · Cited by 38
Designing Personalized Treatment Plans for Breast Cancer
Chen, W., Lu, Y., Qiu, L., & Kumar, S. (2021) · Information Systems Research · doi:10.1287/isre.2021.1002 · Cited by 40
Upshaw, J. N., Ruthazer, R., Miller, K. D., Parsons, S. K., Erban, J. K., O’Neill, A., Demissei, B. G., Sledge, G. W., Wagner, L. I., Ky, B., et al. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2019.04.012 · Cited by 38
Teoh, S., Fiorini, F., George, B., Vallis, K. A., & den Heuvel, F. V. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.06.032 · Cited by 40
“This association is well-established in breast cancer [26] and lymphoma [27].”
BackgroundChung, S. Y., Chang, J. S., Shin, K. H., Kim, J. H., Park, W., Kim, H., Kim, K., Lee, I. J., Yoon, W. S., Cha, J., et al. (2021) · The Breast · doi:10.1016/j.breast.2021.01.003 · Cited by 38
“Considering that smoking cessation greatly reduces the risk of radiation-induced heart disease, patients should be informed of the combined risk of breast complications from smoking and RT, and the benefits of smoking cessation should be emphasized [28].”
BackgroundRadiation-Induced Myocardial Fibrosis in Long-Term Esophageal Cancer Survivors
de Groot, C., Beukema, J. C., Langendijk, J. A., van der Laan, H. P., van Luijk, P., van Melle, J. P., Muijs, C. T., & Prakken, N. H. J. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.02.007 · Cited by 38
Ferini, G., Molino, L., Tripoli, A., Valenti, V., Illari, S. I., Marchese, V. A., CRAVAGNO, I. R., & Borzì, G. R. (2021) · Anticancer Research · doi:10.21873/anticanres.14912 · Cited by 47
Automatic delineation of cardiac substructures using a region‐based fully convolutional network
Harms, J. M., Lei, Y., Tian, S., McCall, N. S., Higgins, K. A., Bradley, J. D., Curran, W. J., Liu, T., & Yang, X. (2021) · Medical Physics · doi:10.1002/mp.14810 · Cited by 38
Bronsart, E., Dureau, S., Xu, H. P., Bazire, L., Chilles, A., Costa, É., Logerot, C., Falcou, M.-C., Campana, F., Berger, F., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.001 · Cited by 38
Proton Therapy for Local-regionally Advanced Breast Cancer Maximizes Cardiac Sparing
Fagundes, M., Hug, E. B., Pankuch, M., Fang, C., McNeeley, S. W., Mao, L., Lavilla, M. A., Schmidt, S. L., Ward, C., Cahlon, O., et al. (2015) · International Journal of Particle Therapy · doi:10.14338/ijpt-14-00025.1 · Cited by 39
Warren, S., Partridge, M., Bolsi, A., Lomax, A., Hurt, C. N., Crosby, T., & Hawkins, M. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.01.044 · Cited by 37
“The doses to lung and heart delivered with setup uncertainties were virtually unchanged for all patients (ie, the same number of patients undergoing VMAT would still not meet the mean heart dose constraint [patients 7, 11, and 17] or lung V 20Gy limit [patients 16 and 21]).”
López‐Fernández, T., & Thavendiranathan, P. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.01.004 · Cited by 43
“In addition, radiation therapy to the chest is associated with the development of coronary artery disease.(84) Cardiac CT has excellent diagnostic performance in the detection of coronary disease and is well known for its high negative predictive value (Figure 4).”
BackgroundT-Type voltage gated calcium channels: a target in breast cancer?
Bhargava, A., & Saha, S. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4970-0 · Cited by 37
Mapping genetic modifiers of radiation-induced cardiotoxicity to rat chromosome 3
Schlaak, R. A., Frei, A. C., Schottstaedt, A. M., Tsaih, S., Fish, B. L., Harmann, L. M., Liu, Q., Gasperetti, T., Medhora, M. M., North, P. E., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00482.2018 · Cited by 37
“significant proportion of patients (10, 47).”
BackgroundCardiovascular Complications Associated with Mediastinal Radiation
Chuy, K. L., Nahhas, O., Dominic, P. S., López, C., Tonorezos, E. S., Sidlow, R., Straus, D., & Gupta, D. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0737-0 · Cited by 38
Characteristics, Management, and Outcomes of Acute Coronary Syndrome Patients with Cancer
Milazzo, V., Cosentino, N., Campodonico, J., Lucci, C., Cardinale, D. M., Cipolla, C. M., & Marenzi, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113642 · Cited by 39
“Coronary ostia and proximal segments are typically involved and the most exposed coronaries are the left anterior descending during left breast irradiation and the left main stem, circumflex, and right coronary arteries during treatment for Hodgkin lymphoma [55].”
BackgroundGu, L., Dai, W., Fu, R., Lu, H., Shen, J., Shi, Y., Zhang, M., Jiang, K., & Wu, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.753209 · Cited by 39
Ferini, G., Valenti, V., Viola, A., Umana, G. E., & Martorana, E. (2022) · Cancers · doi:10.3390/cancers14143477 · Cited by 37
“[3] According to the computing model elaborated by Corradini et al.”
BackgroundMethodHeart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold
Stowe, H. B., Andruska, N. D., Reynoso, F. J., Thomas, M., & Bergom, C. R. (2022) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s282799 · Cited by 50
Azimzadeh, O., Moertl, S., Ramadan, R., Baselet, B., Laiakis, E. C., Sebastian, S., Beaton, D., Hartikainen, J. M., Kaiser, J. C., Beheshti, A., et al. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2110325 · Cited by 40
“High dose, fractionated RT results in an increase in the rate of major coronary events by 7.4% per Gy in breast cancer patients (Darby et al. 2013).”
BackgroundInfluential
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.